Wedbush Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,979
| Closed | -$247K | – | 1053 |
|
|
2022
Q2 | $247K | Sell |
2,979
-386
| -11% | -$32K | 0.01% | 828 |
|
|
2022
Q1 | $259K | Buy |
3,365
+563
| +20% | +$43.3K | 0.01% | 866 |
|
|
2021
Q4 | $248K | Buy |
+2,802
| New | +$248K | 0.01% | 963 |
|
|
2020
Q3 | – | Sell |
-1,738
| Closed | -$214K | – | 944 |
|
|
2020
Q2 | $214K | Sell |
1,738
-1,388
| -44% | -$171K | 0.02% | 752 |
|
|
2020
Q1 | $264K | Buy |
3,126
+535
| +21% | +$45.2K | 0.03% | 570 |
|
|
2019
Q4 | $219K | Buy |
+2,591
| New | +$219K | 0.02% | 823 |
|
|
2018
Q4 | – | Sell |
-2,706
| Closed | -$262K | – | 840 |
|
|
2018
Q3 | $262K | Sell |
2,706
-74
| -3% | -$7.17K | 0.03% | 646 |
|
|
2018
Q2 | $262K | Buy |
+2,780
| New | +$262K | 0.03% | 607 |
|